Syros Pharmaceuticals Stock Investor Sentiment

SYRS Stock  USD 0.27  0.02  8.00%   
Slightly above 56% of all Syros Pharmaceuticals' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Syros Pharmaceuticals suggests that some traders are interested. Syros Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Syros Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
over two weeks ago at thelincolnianonline.com         
Syros Pharmaceuticals Earns Market Perform Rating from JMP Securities
news
over two weeks ago at investing.com         
JMP Securities cuts Syros Pharma stock rating following unsuccessful trial
Investing News at Macroaxis
over two weeks ago at investing.com         
JMP Securities cuts Syros Pharma stock to Market Perform
Investing News at Macroaxis
over two weeks ago at investing.com         
Syros shares rating downgraded after failed SELECT-MDS-1 study
Investing News at Macroaxis
over two weeks ago at seekingalpha.com         
Syros cut to neutral by H.C. Wainwright on failed drug study
seekingalpha News
over two weeks ago at investing.com         
Syros Pharmaceuticals SWOT analysis stock faces headwinds after trial setback
Investing News at Macroaxis
over two weeks ago at benzinga.com         
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
benzinga news
over two weeks ago at businesswire.com         
Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodys...
businesswire News
over two weeks ago at seekingalpha.com         
Syross tamibarotene fails Phase 3 study, triggering possible loan default
seekingalpha News
over two weeks ago at ndtv.com         
Kias Upcoming SUV Christened Syros Will Rival Tata Punch, Maruti Fronx
news
over two weeks ago at www.macroaxis.com         
Acquisition by Fanucci Marsha of 4000 shares of Syros Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over three weeks ago at accesswire.com         
The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securi...
news
over three weeks ago at thelincolnianonline.com         
HC Wainwright Reaffirms Buy Rating for Syros Pharmaceuticals
news
over three weeks ago at finance.yahoo.com         
Syros Pharmaceuticals Third Quarter 2024 Earnings US0.16 loss per share
Yahoo News
over three weeks ago at investing.com         
Earnings call Syros Pharmaceuticals outlines tamibarotene progress
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Syros Pharmaceuticals that are available to investors today. That information is available publicly through Syros media outlets and privately through word of mouth or via Syros internal channels. However, regardless of the origin, that massive amount of Syros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Syros Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Syros Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Syros Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Syros Pharmaceuticals alpha.

Syros Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Syros Stock Analysis

When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.